CLINICAL TRIAL SUMMARY

MDACC Study No:2012-1158 (clinicaltrials.gov NCT No: NCT01932710)
Title:A feasability study of White Blood Cell transfusion for the prevention of infection in Acute Myelogenous Leukemia patients undergoing front-line or first salvage induction therapy
Principal Investigator:Courtney DiNardo
Treatment Agent:White Blood Cell Transfusion
Study Status:Open
Study Description:Patients with leukemia often have low white blood cell counts after
chemotherapy, which puts them at greater risk of infection. The standard of
care for preventing infections is to give these patients antibiotic,
antifungal, and antiviral drugs during the time that white blood cell counts
are low. However, many patients still develop infections during chemotherapy.
Radiated white blood cell transfusions are a standard treatment once a patient
develops a severe infection.

The goal of this clinical research study is to learn if giving white blood cell
transfusions that are not radiated early in chemotherapy might delay or prevent
infections in patients with leukemia. Researchers also want to learn more about
the type and severity of any infections that do occur.

Hide details for General InformationGeneral Information

Disease Group:Leukemia
Phase of Study:Phase II
Treatment Agents:White Blood Cell Transfusion
Treatment Location:Only at MDACC
Estimated Length of Stay in Houston:
Supported By:N/A
Return Visit:
Home Care:


Hide details for Study Contact InformationStudy Contact Information

Physician Name:Courtney DiNardo
Dept:Leukemia
For Clinical Trial Enrollment:713-794-1141
For General Questions about Clinical Trials:1-877-MDA-6789


Show details for Study Objectives / OutcomesStudy Objectives / Outcomes
Show details for Study Status InformationStudy Status Information
Show details for Enrollment EligibilityEnrollment Eligibility
Show details for Resources and LinksResources and Links
Show details for ResultsResults